Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...